Showing results (801-810 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|August 22, 2022
Prognostic risk stratification of gliomas using deep learning in digital pathology imagesPranathi Chunduru, Joanna J Phillips, Annette M Molinaro
Neuro-Oncology Advances|May 7, 2021
Multicellular "hotspots" harbor high-grade potential in lower-grade gliomasAlastair J Kirby, José P Lavrador, Istvan Bodi, et al.
Neuro-Oncology Advances|August 2, 2021
Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessmentKarine A Al Feghali, James W Randall, Diane D Liu, et al.
Neuro-Oncology Advances|August 2, 2021
The spectrum of mitochondrial DNA (mtDNA) mutations in pediatric CNS tumorsKristiyana Kaneva, Katrina O'Halloran, Petr Triska, et al.
Neuro-Oncology Advances|August 11, 2021
Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experienceNazanin K Majd, Maximilan Mastall, Heather Lin, et al.
Neuro-Oncology Advances|September 6, 2021
Inhibition of microglial EZH2 leads to anti-tumoral effects in pediatric diffuse midline gliomasLily Keane, Mathilde Cheray, Dalel Saidi, et al.
Neuro-Oncology Advances|December 1, 2022
Glioma stem cells activate platelets by plasma-independent thrombin production to promote glioblastoma tumorigenesisAnthony R Sloan, Christine Lee-Poturalski, Harry C Hoffman, et al.
Neuro-Oncology Advances|June 30, 2022
Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysisMueez Waqar, Federico Roncaroli, Eric J Lehrer, et al.
Neuro-Oncology Advances|January 12, 2023
Corrigendum to: A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomasChandan Ganesh Bangalore Yogananda, Bhavya R Shah, Frank F Yu, et al.
Neuro-Oncology Advances|May 25, 2022
Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium reportMariko DeWire, Margot Lazow, Olivia Campagne, et al.
Pageof 138